Merck CEO Kenneth Frazier is sticking around. The New Jersey-based pharmaceutical giant said Wednesday that its board of directors had overturned a policy requiring CEOs to retire when they turn ...
Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $103.55 which represents a slight increase of $2.18 or 2.15% from the prior close of $101.37. The stock opened at $101.49 and touched ...
“We hold ourselves to the highest standards of ethics and integrity,” said Robert M. Davis, chairman and chief executive officer, Merck. “A firm belief in the importance of operating responsibly is at ...
Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for neurodegenerative and age-related disorders, including ALS, Alzheimer’s, and ...